J&J | JNJ - Ebitda

Preço das Ações
229.85
Mudança Diária
2.50 1.10%
Mensal
-5.97%
Anual
48.81%
Q2 Previsão
222.63




Ebitda Alterar Data
AbbVie USD 5.37B 1.85B 2025-12
Abbott USD 3.27B 178M 2025-12
Amgen USD 5.14B 775M 2025-12
AstraZeneca USD 5.67B 1.29B 2026-03
Baxter International USD -447M 873M 2025-12
Bayer EUR 1.97B 457M 2025-12
Becton, Dickinson and Co. USD 1.71B 433M 2025-12
Biogen USD 649.7M 76.5M 2026-03
Boston Scientific USD 1.16B 213M 2025-12
Bristol-Myers Squibb USD 2.88B 1.36B 2025-12
CONMED USD 56.39M 23.97M 2026-03
Cooper Companies USD 323.4M 13.2M 2025-12
Dexcom USD 422.2M 53.8M 2025-12
Edwards Lifesciences USD 70.1M 394.2M 2025-12
Eli Lilly USD 12.14B 4.26B 2025-12
Gilead Sciences USD 3.02B 1.01B 2025-12
GlaxoSmithKline GBP 2.77B 1.65B 2026-03
Globus Medical USD 280.46M 27.86M 2025-12
Insulet USD 194M 34M 2025-12
Integra LifeSciences USD 104.21M 25.76M 2025-12
Intuitive Surgical USD 1.09B 165.5M 2025-12
J&J USD 7.19B 2.32B 2025-12
Medtronic USD 2.93B 482M 2025-12
Merck USD 6.3B 2.09B 2025-12
Merit Medical Systems USD 97.23M 17.69M 2025-12
Novartis USD 5.3B 530M 2026-03
Pfizer USD 6.08B 351M 2025-09
Regeneron Pharmaceuticals USD 1.2B 718.4M 2025-12
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 3.31B 3.65B 2026-03
Stryker USD 2.19B 519M 2025-12
Tandem Diabetes Care USD 32.9M 30.13M 2025-12
Teva Pharmaceutical Industries USD 1.06B 582M 2026-03
Vertex Pharmaceuticals USD 1.44B 100.4M 2025-09
Zimmer Biomet Holdings USD 759M 120.8M 2025-12
Zoetis USD 1.04B 87M 2025-09